Nu-Med Plus (NUMD) Share-based Compensation Growth (3y) (2015 - 2022)
Powered by 
Analysis
Nu-Med Plus (NUMD) Share-based Compensation Growth (3y) (2015 - 2022) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 8.37% |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | -22.92% |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 19.64% |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | -28.31% |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 0.55% |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 4.11% |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | 7.30% |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | -0.59% |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 3.40% |
| 10 | Nu-Med Plus | 1.67 Mn | 1.67 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2022 | -11.21% |
| Dec 31, 2021 | -84.03% |
| Mar 31, 2021 | 143.77% |
| Dec 31, 2020 | 137.53% |
| Sep 30, 2020 | 51.93% |
| Dec 31, 2019 | 21.59% |
| Sep 30, 2019 | 30.60% |
| Jun 30, 2019 | -63.16% |
| Dec 31, 2018 | 3.26% |
| Sep 30, 2018 | 37.19% |
| Jun 30, 2018 | -38.76% |
| Mar 31, 2018 | -9.45% |
| Dec 31, 2017 | -27.05% |
| Sep 30, 2017 | -49.98% |
| Dec 31, 2016 | 99.71% |
| Sep 30, 2016 | -90.77% |
| Jun 30, 2016 | 1,144.35% |
| Dec 31, 2015 | 88.05% |
| Sep 30, 2015 | 109.44% |
| Jun 30, 2015 | 215.97% |